Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-1262: hsa-mir-1262 is a microRNA that has been identified as a potential biomarker for the earlier and more precise diagnosis of treatment-resistant schizophrenia (TRS) [PMC7533444]. It is a small non-coding RNA molecule that plays a role in gene regulation and has been found to be dysregulated in various diseases [PMC7533444]. In the context of TRS, hsa-mir-1262 has been proposed as one of the major biomarkers, along with hsa-miR-218-5p, for improving diagnosis and treatment [PMC7533444].
In terms of target genes, hsa-miR-218-5p was found to have 187 predicted target genes, while hsa-mir-1262 had only 51 target genes identified [PMC7533444]. These target genes are potential candidates for further investigation into the underlying mechanisms of TRS and could potentially be targeted for gene-based diagnosis and treatment strategies [PMC7533444].
Overall, the identification of hsa-mir-1262 as a potential biomarker for TRS opens up new possibilities for improving diagnostic accuracy and developing more targeted treatment approaches. Further research is needed to fully understand the role of hsa-mir-1262 in TRS and its potential implications for personalized medicine in psychiatric disorders.
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset